Kate Haviland sold $1.4M of Blueprint Medicines (BPMC)

Executed Mar 5 2025, disclosed Mar 7 2025, 2 days later.

Value, as filed

$1.4M

16,151 sh × $88.80

Executed

Mar 5 2025

the trade date, as filed

Disclosed

Mar 7 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

KH Kate Haviland CHIEF EXECUTIVE OFFICER profile →

Kate Haviland (CHIEF EXECUTIVE OFFICER) filed 4 Form 4 reports in the past 24 months (0 purchases, 4 sales), most often in BPMC. The largest single filing was $1.4M of BPMC (16,151 sh × $88.80, as filed), executed Mar 5 2025.

The name

BPMC BPMC BPMC · 35 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kate Haviland in BPMC

BPMCSALE Blueprint Medicines Corp $105K
1,200 sh × $87.34
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp $159K
1,446 sh × $110.24
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp $169K
1,746 sh × $96.74
Exec Nov 29 2024
Filed Dec 3 2024 · 5:30 PM ET